Santen Pharm CO ADR (SNPHY)

11.44
+0.74 (6.92%)
OP · Last Trade: Sep 17th, 7:39 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.70
Open11.32
Bid-
Ask-
Day's Range11.32 - 11.51
52 Week Range9.220 - 13.93
Volume1,523
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume1,507

Chart

News & Press Releases

Santen Joins Inaugural Global Summit for Eye Health as High-Impact Partner
By Santen Pharmaceutical Co., Ltd. · Via JCN Newswire · August 5, 2026
SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023investorplace.com
Santen Pharmaceutical just reported results for the fourth quarter of 2023.
Via InvestorPlace · May 17, 2024
Current Analysis: Santen Pharmaceuticaltalkmarkets.com
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market close
Via Talk Markets · February 15, 2024